IRCT20200407046981N48招募中未知
Comparative bioequivalence study of the Methylphenidate10-mg Tablets manufactured by Vana Darou Gostar Company with Methylphenidate brand tablets (Ritalin ®) by Novartis company
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- Male
入选标准
- •The weight limit of each volunteer should be between 60 and 100 kg.
- •All volunteers must be non-smokers.
- •All volunteers must be non-smokers.
- •They must be healthy in terms of liver, kidney, respiratory system, mental and other general health characteristics that will be assessed.
- •Candidates who have consented to the consent form.
排除标准
- •Known hypersensitivity or idiosyncratic reaction to Methylphenidate or any ingredients.
- •Subjects with BP = 90/60 mm/Hg or BP = 140/90 mm/Hg.
- •Taking any medicine during two week before dosing.
研究者
相似试验
已完成
不适用
Comparison between therapeotic effects of methylphenidate with rispredone in cristal dependent patientsmethamphetamin dependency.T43.6IRCT201202159018N1Tavana clinic60
尚未招募
不适用
Study of absorption and elimination rate of Dimethyl Fumarate 240-mg capsule in comparison with Dimethyl Fumarate brand Capsule (Tecfidera®).Bioequivalence study.IRCT20200407046981N27Avicenna Pharmaceutical Company24
招募中
Unknown
Bioequivalence study of methylphenidate hydrochloride 10 mg tabletIRCT20230222057495N15Jalinous Pharmaceutical Company24
已完成
Unknown
Metoprolol succinate tablet BioequivalenceIRCT20130313012810N37Raha Pharmaceutical Company24
已完成
Unknown
Bioequivalence study of the Metoprolol succinateBioequivalence study in healthy volunteers.IRCT20130313012810N36Koushan Pharmed Pharmaceutical Company24